Pancreatic Cancer Research

ResearcherHumboldt-Universität zu BerlinActive in the last 2 years

Matthäus Felsenstein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3146-8717; OpenAlex author ID A5043226672, A5057540279. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 7 papers

Papers 13

  1. Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study. Co-author DOI 10.1002/cam4.71490↗
  2. Targeting the stromal-immune barrier: A novel strategy to overcome resistance to CLDN18.2/CD3 bispecific T-cell engager therapy in pancreatic cancer. First author DOI 10.1016/j.canlet.2026.218248↗
  3. The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pan… Co-author DOI 10.1016/j.ejca.2025.116189↗
  4. R0 Resection improves survival after multivisceral resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2026.117352↗
  5. Federated CT foundation models for multi-center detection of lymph node metastasis in pancreatic cancer. Co-author DOI 10.1038/s41598-026-47631-2↗
  6. Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer models. Co-author DOI 10.1038/s41598-026-47856-1↗
  7. Virtual reality volumetric rendering versus cross-sectional imaging for pancreatic cancer resectability assessment: a pilot randomized controlled reader study. Co-author DOI 10.1186/s42234-026-00202-2↗
  8. Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids. Co-author DOI 10.1186/s12935-025-03969-7↗
  9. Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last Decade. Co-author DOI 10.3390/cancers15082367↗
  10. Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022… Co-author DOI 10.3390/jcm12216947↗
  11. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? Co-author DOI 10.3390/jcm11092367↗
  12. Cancer Associated Fibroblasts Derived from Pancreatic Adenocarcinoma and Their Role in Cell Migration. Co-author DOI 10.21873/anticanres.15227↗
  13. Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival. Co-author DOI 10.1016/j.ejso.2018.05.002↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Uwe Pelzer · 8 shared papers, 2018–2026 · strength 1.44
  2. Christopher Neumann · 6 shared papers, 2021–2026 · strength 1.20
  3. Marcus Bahra · 6 shared papers, 2018–2026 · strength 1.12
  4. Mihnea Paul Dragomir · 4 shared papers, 2025–2026 · strength 0.90
  5. François Schneider · 4 shared papers, 2023–2026 · strength 0.83
  6. Uli Fehrenbach · 4 shared papers, 2022–2026 · strength 0.83
  7. Katharina Wansch · 3 shared papers, 2025–2026 · strength 0.67
  8. Florian Dölvers · 3 shared papers, 2025–2026 · strength 0.67
  9. Thomas Malinka · 4 shared papers, 2018–2026 · strength 0.63
  10. Lea Timmermann · 3 shared papers, 2022–2026 · strength 0.54
  11. Muhammad Imtiaz Ashraf · 1 shared paper, 2026 · strength 0.39
  12. S.-Y. Liu · 1 shared paper, 2026 · strength 0.39
  13. Parinishtha Bhalla · 1 shared paper, 2026 · strength 0.29
  14. Alexander Semaan · 1 shared paper, 2026 · strength 0.29
  15. Shadi Albarqouni · 1 shared paper, 2026 · strength 0.29
  16. Christian Benzing · 2 shared papers, 2022–2023 · strength 0.28
  17. Bruno Valentin Sinn · 2 shared papers, 2022–2023 · strength 0.28
  18. Mengwen Hu · 2 shared papers, 2022–2023 · strength 0.28
  19. Moritz Queisner · 1 shared paper, 2026 · strength 0.26
  20. Karl Eisenträger · 1 shared paper, 2026 · strength 0.26
  21. Benjamin Struecker · 1 shared paper, 2026 · strength 0.26
  22. Ellen von Hoerschelmann · 1 shared paper, 2021 · strength 0.13
  23. Rosa Bianca Schmuck · 1 shared paper, 2021 · strength 0.13
  24. Fritz Klein · 1 shared paper, 2018 · strength 0.09
  25. Timm Denecke · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.